Kidtrayze (Zinc Chloride, Potassium Iodide, Sodium Selenite, Copper Chloride Dihydrate, Manganese Chloride Tetr)

The trace elements in Kidtrayze act as cofactors for a variety of enzymes. Zinc supports immune function and protein synthesis; iodine is required for thyroid hormone production; selenium contributes to antioxidant enzymes; copper is essential for connective‑tissue formation; and manganese participates in carbohydrate metabolism. Together they restore physiological concentrations needed for normal cellular processes.

The dose of Kidtrayze is individualized. The prescribing clinician determines the amount and infusion rate based on the patient’s laboratory values, nutritional status, and clinical condition. No fixed regimen is provided in public information; dosing must follow the healthcare professional’s order.

Safety data for Kidtrayze in pregnancy and lactation are limited. It should be used only when clearly indicated after a careful risk‑benefit assessment by the treating physician. The decision depends on the severity of the trace‑element deficiency and the potential impact on maternal and fetal health.

To order Kidtrayze, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Kidtrayze combines five essential trace elements in a single intravenous formulation, which can simplify compounding compared with using separate single‑element solutions. Some alternatives provide only one or two elements, requiring multiple infusions. The comprehensive blend of Kidtrayze may reduce preparation time and potential compatibility issues, while still allowing clinicians to adjust individual element doses if needed.

Kidtrayze must be stored at 2‑8 °C. Keep the vials refrigerated, protect them from light, and avoid freezing or shaking the container. Before use, inspect the solution for particulate matter or discoloration and discard if any abnormalities are observed.

Kidtrayze is administered intravenously, typically diluted in a compatible carrier fluid such as 5 % dextrose or normal saline. The infusion rate is set by the prescribing clinician and may be adjusted based on the patient’s tolerance and laboratory monitoring. Administration should follow aseptic technique and be monitored for any adverse reactions.

The most serious risks associated with Kidtrayze include anaphylactic reactions, copper toxicity (manifesting as liver dysfunction or neurological signs), selenium excess (selenosis) with symptoms like hair loss or respiratory irritation, and severe electrolyte imbalances that can affect cardiac or neurological function. Prompt recognition and medical intervention are essential if these events occur.

Kidtrayze should be avoided in individuals with a known hypersensitivity to any of its components. Patients with uncontrolled severe hepatic or renal disease may require alternative management, and those receiving incompatible intravenous medications should be assessed for potential precipitation. The product is also contraindicated in patients for whom trace‑element supplementation is not clinically indicated.